B. Metzler seel. Sohn & Co. Holding AG Makes New Investment in Azenta, Inc. (NASDAQ:AZTA)

B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of Azenta, Inc. (NASDAQ:AZTA) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 40,857 shares of the company’s stock, valued at approximately $1,979,000. B. Metzler seel. Sohn & Co. Holding AG owned 0.08% of Azenta at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in AZTA. Hantz Financial Services Inc. acquired a new position in Azenta during the 2nd quarter worth approximately $30,000. Farther Finance Advisors LLC raised its position in shares of Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after purchasing an additional 256 shares during the period. Benjamin F. Edwards & Company Inc. grew its position in Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after purchasing an additional 955 shares during the period. Lazard Asset Management LLC bought a new stake in Azenta during the 1st quarter valued at $130,000. Finally, Acadian Asset Management LLC raised its holdings in Azenta by 24.7% during the first quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after buying an additional 471 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Insider Buying and Selling at Azenta

In related news, CEO John Marotta purchased 12,717 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The shares were bought at an average cost of $39.48 per share, with a total value of $502,067.16. Following the acquisition, the chief executive officer now owns 99,612 shares of the company’s stock, valued at $3,932,681.76. This represents a 14.63 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Herman Cueto sold 712 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $40.07, for a total transaction of $28,529.84. Following the sale, the chief financial officer now owns 23,892 shares of the company’s stock, valued at $957,352.44. This trade represents a 2.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 3,018 shares of company stock worth $126,689 in the last quarter. 1.77% of the stock is currently owned by company insiders.

Azenta Price Performance

AZTA opened at $45.51 on Friday. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $69.16. The firm has a market capitalization of $2.23 billion, a P/E ratio of -15.32 and a beta of 1.48. The company’s 50-day moving average is $45.29 and its 200 day moving average is $50.19.

Azenta (NASDAQ:AZTA) last posted its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million for the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The company’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.13 EPS. On average, equities research analysts expect that Azenta, Inc. will post 0.4 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Evercore ISI decreased their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research report on Tuesday, October 1st. Needham & Company LLC decreased their price objective on Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Azenta has a consensus rating of “Hold” and an average price target of $63.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.